stock.name

Stryker Corp.

SYK

Market Cap$134.31B
Close$

Compare Stryker

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Stryker Corp.Stryker Corp.42.40.86%17%6.80.7
marketMarket Avg59.61.27%31%6.41
HealthcareHealthcare Avg62.31.27%15%7.30.9

Earnings Call Q4 2023

January 30, 2024 - AI Summary

Stryker reported strong Q4 and full-year 2023 results, with sales growth of over 11% for both periods.
The company expects to continue delivering high sales growth in 2024, with organic sales growth projected to be between 7.5% and 9%.
Stryker's focus on innovation and acquisitions will drive future growth, with a pipeline of new product launches planned for 2024.

Exclusive for Stockcircle Pro members

Sign upSign Up
$360.36

Current Fair Value

0.5% upside

Undervalued by 0.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$134.31 Billion
Enterprise Value$144.25 Billion
Dividend Yield$3.0379 (0.86%)
Earnings per Share$8.25
Beta0.67
Outstanding Shares379,938,000
Avg 30 Day Volume1,141,095

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio42.44
PEG41.19
Price to Sales6.77
Price to Book Ratio7.47
Enterprise Value to Revenue7.04
Enterprise Value to EBIT36.93
Enterprise Value to Net Income45
Total Debt to Enterprise0.09
Debt to Equity0.7

Revenue Sources

No data

ESG Score

No data

About Stryker Corp.

40,000 employees
CEO: Kevin Lobo

Stryker is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neur...